HYPR Stock Analysis: Buy, Sell, or Hold?
HYPR - Hyperfine, Inc. Class A Common Stock
$0.99
0.05 (5.26%)
▲
5d:
+2.55%
30d:
-24.23%
90d:
-47.33%
BUY
HIGH Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026
2d
Get Alerted When HYPR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: HYPR shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
✅ BUY SIGNAL: HYPR shows strong fundamentals and good volume confirmation. Solid entry point despite slightly low pricing.
In-depth Analysis How we analyze
Valuation Analysis: HYPR is currently trading at $0.98, which is considered slightly low relative to its 30-day fair value range of $0.90 to $1.31.
Technical Outlook: Technically, HYPR is showing sideways momentum. Immediate support is located at $0.88, while resistance sits at $1.02. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.17 (+131.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HYPR is showing sideways momentum. Immediate support is located at $0.88, while resistance sits at $1.02. The stock is showing strong short-term momentum, up 5.3% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.17 (+131.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$0.90 -
$1.31
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.3%)
- BULLISH: Trading 131.5% below Wall St target ($2.17)
Trading Range Analysis
30-Day Trading Range
$0.90 -
$1.31
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$0.88
Resistance Level
$1.02
Current Trend
Sideways
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.75
Wall Street Target
$2.17
(+131.5%)
Revenue Growth (YoY)
82.6%
Profit Margin
-226.9%
Share & Embed Analysis
Last updated: August 03, 2026 1:31 PM ET
Data refreshes hourly during market hours. Next update: 2:31 PM
Data refreshes hourly during market hours. Next update: 2:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HYPR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
Brett Hale
SELL
24188 shares
2026-03-23
Thomas Teisseyre
SELL
24188 shares
2026-03-23
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$64 | 55 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$93 | 49 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$384 | 51 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$118 | 52 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$236 | 51 HOLD |
Advanced HYPR Option Strategies
Professional options setups generated by AI based on today's HYPR price and gamma walls.
